Article ID Journal Published Year Pages File Type
6020220 Journal of Neuroimmunology 2015 4 Pages PDF
Abstract
We showed increased serum latency activated peptide (LAP) of TGF-β levels in MS patients treated with vitamin D3. The immune regulatory effects of TGF-beta may play a role in the improved MRI outcomes that we observed earlier in the vitamin D treated group of patients.
Keywords
Related Topics
Life Sciences Immunology and Microbiology Immunology
Preview
Vitamin D3 administration to MS patients leads to increased serum levels of latency activated peptide (LAP) of TGF-beta
Authors
, , , ,